134 related articles for article (PubMed ID: 1534330)
1. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
Slowinska-Srzednicka J; Zgliczynski W; Makowska A; Jeske W; Brzezinska A; Soszynski P; Zgliczynski S
J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
[TBL] [Abstract][Full Text] [Related]
2. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
3. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
4. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries.
Prelević GM; Wurzburger MI; Balint-Perić L; Ginsburg J
Horm Res; 1992; 37(4-5):125-31. PubMed ID: 1490653
[TBL] [Abstract][Full Text] [Related]
6. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome.
Kazer RR; Unterman TG; Glick RP
J Clin Endocrinol Metab; 1990 Oct; 71(4):958-62. PubMed ID: 2401719
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
Esposito V; Federico P; Lo Iudice G; Rispoli C; Sabatino P; D'Alessandro B
Minerva Endocrinol; 1992; 17(1):21-9. PubMed ID: 1495451
[TBL] [Abstract][Full Text] [Related]
8. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
9. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
[TBL] [Abstract][Full Text] [Related]
10. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
13. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
[TBL] [Abstract][Full Text] [Related]
14. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.
Lee EJ; Nam SY; Kim KR; Lee HC; Cho JH; Nam MS; Song YD; Lim SK; Huh KB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2495-8. PubMed ID: 7629249
[TBL] [Abstract][Full Text] [Related]
15. Dysfunction of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome.
Piaditis GP; Kounadi TG; Rangou DB; Trovas GP; Kaklas NA; Tzonou AJ; Chlouverakis CS
Clin Endocrinol (Oxf); 1995 Jun; 42(6):635-40. PubMed ID: 7634505
[TBL] [Abstract][Full Text] [Related]
16. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.
Nestler JE; Barlascini CO; Matt DW; Steingold KA; Plymate SR; Clore JN; Blackard WG
J Clin Endocrinol Metab; 1989 Jun; 68(6):1027-32. PubMed ID: 2498378
[TBL] [Abstract][Full Text] [Related]
17. Glucagon in women with polycystic ovary syndrome (PCO): relationship to abnormalities of insulin and androgens.
Golland IM; Vaughan Williams CA; Shalet SM; Laing I; Elstein M
Clin Endocrinol (Oxf); 1990 Nov; 33(5):645-51. PubMed ID: 2147602
[TBL] [Abstract][Full Text] [Related]
18. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
Bellantoni MF; Harman SM; Cho DE; Blackman MR
J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa.
De Marinis L; Folli G; D'Amico C; Mancini A; Sambo P; Tofani A; Oradei A; Barbarino A
J Clin Endocrinol Metab; 1988 Mar; 66(3):598-604. PubMed ID: 3127419
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
